Genotype-phenotype correlations in von Hippel-Lindau disease

被引:178
作者
Ong, Kai Ren
Woodward, Emma R.
Killick, Pip
Lim, Caron
Macdonald, Fiona
Maher, Eamorm R. [1 ]
机构
[1] Univ Birmingham, Sect Med & Mol Genet, Inst Biomed Res, Canc Res UK Renal Mol Oncol Grp, Birmingham B15 2TT, W Midlands, England
[2] Birmingham Womens Hosp, Dept Clin Genet, Birmingham, W Midlands, England
[3] Birmingham Womens Hosp, Reg Mol Genet Lab, Birmingham, W Midlands, England
关键词
VHL; genotype-phenotype; pheochromocytoma; TUMOR-SUPPRESSOR GENE; RENAL-CELL CARCINOMA; VHL GENE; GERMLINE MUTATIONS; CHUVASH POLYCYTHEMIA; NATURAL-HISTORY; FAMILIES; PHEOCHROMOCYTOMA; IDENTIFICATION; PROTEIN;
D O I
10.1002/humu.20385
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
von Hippel,Lindau (VHL) disease is a dominantly inherited familial cancer syndrome resulting from mutations in the VHL tumor suppressor gene. VHL disease displays marked variation in expression and the presence of pheochromocytoma has been linked to missense VHL mutations. We analyzed genotype-phenotype correlations in 573 individuals with VHL disease. Routine clinical and radiological surveillance of VHL patients and at-risk relatives was associated with increased detection of retinal angiomatosis (73 vs. 59% of cases) and a reduction in age at diagnosis of renal cell carcinoma (RCC) (44.0 +/- 10.9 vs. 39.7 +/- 10.3 years). We confirmed the association of pheochromocytoma with missense mutations described previously, but stratifying missense mutations into those that resulted in substitution of a surface amino acid and those that disrupted structural integrity demonstrated that surface amino acid substitutions conferred a higher pheochromocytoma risk. Age at first manifestation of VHL disease was significantly earlier (P = 0.001), and age-related risks of retinal angiomas and RCC were higher (P = 0.022 and P = 0.0008, respectively) in individuals with a nonsense or frameshift mutation than in those with deletions or missense mutations that disrupted the structural integrity of the VHL gene product (pVHL). These results extend genotype-phenotype-protein structure correlations in VHL disease and provide a baseline for future chemoprevention studies in VHL disease.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 49 条
[21]  
KUZMIN I, 1995, ONCOGENE, V10, P2185
[22]  
LAMIELL JM, 1989, MEDICINE, V68, P1
[23]   The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation:: a new facet to Knudson's 'two-hit' hypothesis [J].
Lamlum, H ;
Ilyas, M ;
Rowan, A ;
Clark, S ;
Johnson, V ;
Bell, J ;
Frayling, I ;
Efstathiou, J ;
Pack, K ;
Payne, S ;
Roylance, R ;
Gorman, P ;
Sheer, D ;
Neale, K ;
Phillips, R ;
Talbot, I ;
Bodmer, W ;
Tomlinson, I .
NATURE MEDICINE, 1999, 5 (09) :1071-1075
[24]   IDENTIFICATION OF THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE [J].
LATIF, F ;
TORY, K ;
GNARRA, J ;
YAO, M ;
DUH, FM ;
ORCUTT, ML ;
STACKHOUSE, T ;
KUZMIN, I ;
MODI, W ;
GEIL, L ;
SCHMIDT, L ;
ZHOU, FW ;
LI, H ;
WEI, MH ;
CHEN, F ;
GLENN, G ;
CHOYKE, P ;
WALTHER, MM ;
WENG, YK ;
DUAN, DSR ;
DEAN, M ;
GLAVAC, D ;
RICHARDS, FM ;
CROSSEY, PA ;
FERGUSONSMITH, MA ;
LEPASLIER, D ;
CHUMAKOV, I ;
COHEN, D ;
CHINAULT, AC ;
MAHER, ER ;
LINEHAN, WM ;
ZBAR, B ;
LERMAN, MI .
SCIENCE, 1993, 260 (5112) :1317-1320
[25]   Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer [J].
Lee, S ;
Nakamura, E ;
Yang, HF ;
Wei, WY ;
Linggi, MS ;
Sajan, MP ;
Farese, RV ;
Freeman, RS ;
Carter, BD ;
Kaelin, WG ;
Schlisio, S .
CANCER CELL, 2005, 8 (02) :155-167
[26]   Pancreatic neuroendocrine tumors associated with vonHippel Lindau disease: Diagnostic and management recommendations [J].
Libutti, SK ;
Choyke, PL ;
Bartlett, DL ;
Vargas, H ;
Walther, M ;
Lubensky, I ;
Glenn, G ;
Linehan, WM ;
Alexander, HR .
SURGERY, 1998, 124 (06) :1153-1159
[27]   The worldwide distribution of the VHL 598C>T mutation indicates a single founding event [J].
Liu, EL ;
Percy, MJ ;
Amos, CI ;
Guan, YL ;
Shete, S ;
Stockton, DW ;
McMullin, MF ;
Polyakova, LA ;
Ang, SO ;
Pastore, YD ;
Jedlickova, K ;
Lappin, TRJ ;
Gordeuk, V ;
Prchal, JT .
BLOOD, 2004, 103 (05) :1937-1940
[28]   Von Hippel-Lindau disease [J].
Maher, ER .
CURRENT MOLECULAR MEDICINE, 2004, 4 (08) :833-842
[29]   CLINICAL-FEATURES AND NATURAL-HISTORY OF VONHIPPEL-LINDAU DISEASE [J].
MAHER, ER ;
YATES, JRW ;
HARRIES, R ;
BENJAMIN, C ;
HARRIS, R ;
MOORE, AT ;
FERGUSONSMITH, MA .
QUARTERLY JOURNAL OF MEDICINE, 1990, 77 (283) :1151-1163
[30]   Phenotypic expression in von Hippel-Lindau disease: Correlations with germline VHL gene mutations [J].
Maher, ER ;
Webster, AR ;
Richards, FM ;
Green, JS ;
Crossey, PA ;
Payne, SJ ;
Moore, AT .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (04) :328-332